SCHEMBL2846480

SCHEMBL2846480

O=C(O)NCCc1ccc(-c2ccccc2)nc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 1/20 0.52
TP53 P04637 2/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
LDHA P00338 1/20 0.49
MAPT P10636 1/20 0.48
HIF1A Q16665 3/20 0.48
CYP11B1 P15538 6/20 0.48
CYP11B2 P19099 6/20 0.48
WNT3A P56704 2/20 0.47
HDAC1 Q13547 1/20 0.47
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
BAZ2B Q9UIF8 1/20 0.47
PDCD1 Q15116 1/20 0.46
CD274 Q9NZQ7 1/20 0.46
CYP3A4 P08684 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2840775 0.84 HPGDS (0.46) HPGDSTP53NPC1RAB9ASMN1; SMN2
SCHEMBL2840773 0.83 HPGDS (0.45) HPGDSTP53NPC1RAB9ASMN1; SMN2
SCHEMBL2412802 0.83 LMNA (0.53) HPGDSSMN1; SMN2MAPTHIF1A
SCHEMBL6027765 0.82 HPGDS (0.44) HPGDSTP53NPC1RAB9ASMN1; SMN2
SCHEMBL17261484 0.82 EPHX2 (0.49) HPGDSTP53NPC1RAB9ASMN1; SMN2
SCHEMBL17273999 0.82 CKS1B (0.50) HPGDSTP53NPC1RAB9ASMN1; SMN2
SCHEMBL17261555 0.82 ALDH1A1 (0.50) NPC1RAB9ASMN1; SMN2
SCHEMBL2843167 0.81 HPGDS (0.55) HPGDSNPC1RAB9ASMN1; SMN2HIF1A
SCHEMBL23828889 0.81 HCAR2 (0.55) TP53NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL6027764 0.81 HPGDS (0.43) HPGDSTP53NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015172196-A1 HETEROCYCLIC COMPOUNDS AND USE OF SAME MONASH UNIVERSITY (AU) 2015-11-19 WO disclosed
EP-2251324-A1 HETEROARYL-ALKYLCARBAMATE COMPOUNDS AND THEIR USE AS INHIBITORS OF THE FAAH ENZYME Sanofi-Aventis (FR) 2010-11-17 EP disclosed
EP-1720829-B1 DERIVATIVES OF HETEROARYL-ALKYLCARBAMATES, PREPARATION METHOD THEREOF AND USE OF SAME AS FAAH ENZYME INHIBITORS SANOFI AVENTIS (FR) 2009-10-14 EP disclosed
EP-1720829-A1 DERIVATIVES OF HETEROARYL-ALKYLCARBAMATES, PREPARATION METHOD THEREOF AND USE OF SAME AS FAAH ENZYME INHIBITORS Sanofi-Aventis (FR) 2006-11-15 EP disclosed
WO-2005090292-A1 DERIVATIVES OF HETEROARYL-ALKYLCARBAMATES, PREPARATION METHOD THEREOF AND USE OF SAME AS FAAH ENZYME INHIBITORS SANOFI-AVENTIS (FR) 2005-09-29 WO disclosed